Navigation Links
ABR-Affinity BioReagents to Exhibit at the Society for Biomolecular Sciences in St. Louis, April 6 - 10, 2008
Date:4/2/2008

DENVER and GOLDEN, Colo., April 2, 2008 /PRNewswire/ -- ABR-Affinity BioReagents, a leading global antibody manufacturer, announced today that it will exhibit for the first time at the 14th Annual Conference and Exhibition of the Society for Biomolecular Sciences (SBS) in St. Louis, April 6 - 10, 2008.

"We are extremely pleased to support the advancement of the science of drug discovery by exhibiting at the SBS meeting, especially as it is a non-profit forum. This is our first in what I foresee as a multiple year commitment to supporting this cutting edge area of basic and applied pharmaceutical research," said Ken Wilczek, President of ABR. "It is truly a privilege to be involved with these top-level, dedicated institutions and talented individuals in the furtherance of innovative drug discovery research that could lead to potentially life-saving therapies," continued Mr. Wilczek. ABR-Affinity BioReagents' high quality portfolio of monoclonal and polyclonal antibodies, recombinant proteins, siRNA and custom antibody and peptide production services are already in use by every major research institution, government agency, university, and pharmaceutical company in the world today.

"Feedback from leading researchers in the areas of cancer biology and disease research, especially arthritis and inflammation, is invaluable to us in determining strategic direction. The international character of this audience will enable ABR to collaborate on a meaningful level with the most influential scientists in the world," noted Mr. Wilczek. ABR-Affinity BioReagents will be located at booth #220.

About ABR-Affinity BioReagents

Founded in 1989 with world headquarters in Golden, Colorado, ABR-Affinity BioReagents is a world leader in the manufacture and distribution of monoclonal and polyclonal antibodies, kits, recombinant proteins, siRNA, and custom antibody production services, known as Antibody on Demand(R).

With more than 35,000 antibodies focused in 43 research areas, ABR offers a unique value proposition in the life science industry -- research antibodies that are 100% quality guaranteed or your money back -- with no questions asked.

Utilizing a distribution network encompassing over 55 nations, ABR products are readily available in every research market on the globe. Products are available directly from ABR in the United States, as well as through an exclusive distribution partnership with Fisher Scientific, a division of Thermo Fisher Scientific.

For additional information about ABR-Affinity BioReagents, contact Leslie Martin with ABR media relations at 1-800-527-4535.


'/>"/>
SOURCE ABR-Affinity BioReagents
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ABR-Affinity BioReagents Finalizes Agreement for Distribution of Osenses Antibodies in the U.S., Canada and Europe
2. ABR-Affinity BioReagents to Exhibit at ASCB in Washington D.C., December 1 - 5, 2007
3. ABR-Affinity BioReagents Announces Agreements for U.S. Distribution of Research Antibodies
4. Corgenix to Exhibit AspirinWorks(R) Test at ACC 2008 Meeting in Chicago
5. Atherotech to Exhibit the VAP Test (R) at ACC 2008 Meeting in Chicago
6. Biotechnology Leader to Exhibit at Upcoming Trade Show
7. BioInformatics, LLC Studies Trade Show Exhibition Strategies in the Life Science Market
8. West Michigan Science & Technology Initiative Seeks Exhibitors for Annual Life Science Showcase
9. Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2
10. Imaging Diagnostic Systems Exhibits at Major Middle East Health Conference
11. Kiwa Bio-Tech Products Group Holds a Fertilizer Products Exhibition in Hebei
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... N.Y. , Dec. 2, 2016 More than ... (CSHL) 11th Double Helix Medals dinner ( DHMD ). The gala was ... New York City and honored ... their contributions, respectively, to health and medicine and the public ... Ali in 2006, the event has raised $40 million ...
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ACEA Biosciences, ... its Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer ... providing an update on the phase I/II clinical trials for AC0010 in patients with ...
(Date:12/2/2016)... ... , ... DrugDev believes the only way to achieve real change ... three tenets were on display at the 2nd Annual DrugDev User Summit (hosted by ... and site organizations to discuss innovation and the future of clinical research. , ...
(Date:12/2/2016)... 2, 2016 The immunohistochemistry (IHC) market ... a CAGR of 7.3% during the forecast period of 2016 to ... laboratories segment accounted for the largest share of immunohistochemistry (IHC) market, ... , ... immunohistochemistry (IHC) market spread across 225 pages, profiling 10 companies and ...
Breaking Biology Technology:
(Date:6/22/2016)... -- The American College of Medical Genetics and Genomics was once ... one of the fastest-growing trade shows during the Fastest 50 ... Las Vegas . Winners ... each of the following categories: net square feet of paid ... The 2015 ACMG Annual Meeting was ranked 23 out of ...
(Date:6/20/2016)... -- Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring announced that after exhaustive ... the final acceptance by all three (3) Department ... (MAS) installed. Furthermore, Securus will have contracts for ... October, 2016. MAS distinguishes between legitimate wireless device ...
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
Breaking Biology News(10 mins):